Tom Walley
Impact in
- Family Practice top 2%
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 33
- Pharmaceutical Economics and Policy 16
- Healthcare Policy and Management 8
-
- Primary Care and Health Outcomes 7
- Healthcare cost, quality, practices 5
- Co-authors
- Helen Prosser (5 shared papers)Simon Maxwell (1 shared paper)Alan Haycox (10 shared papers)Dyfrig Hughes (4 shared papers)Elías Mossialos (4 shared papers)Monique F. Mrazek (2 shared papers)A Bagust (3 shared papers)Rumona Dickson (7 shared papers)
- Journals
- PharmacoEconomics (10 papers)Pharmacoepidemiology and Drug Safety (6 papers)British Journal of Clinical Pharmacology (4 papers)Social Science & Medicine (3 papers)International Journal of Technology Assessment in Health Care (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Tom Walley
77 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 136
- Family Practice 90
- Geriatrics and Gerontology 161
- Medical Terminology 7
- Applied Microbiology and Biotechnology 53
- Economics and Econometrics 559
Countries citing papers authored by Tom Walley
This map shows the geographic impact of Tom Walley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Walley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Walley more than expected).
Fields of papers citing papers by Tom Walley
This network shows the impact of papers produced by Tom Walley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Walley. The network helps show where Tom Walley may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Walley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 166 | |
| 2 | Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality | 2004 | 140 |
| 3 | 2001 | 136 | |
| 4 | 2004 | 126 | |
| 5 | 2004 | 102 | |
| 6 | 1997 | 94 | |
| 7 | 2001 | 88 | |
| 8 | 2009 | 78 | |
| 9 | 2001 | 62 | |
| 10 | 2005 | 48 | |
| 11 | 2004 | 46 | |
| 12 | 2003 | 45 | |
| 13 | 2022 | 40 | |
| 14 | Understanding why GPs see pharmaceutical representatives: a qualitative interview study. | 2003 | 33 |
| 15 | 2011 | 31 | |
| 16 | 2008 | 30 | |
| 17 | 2003 | 28 | |
| 18 | Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. | 1999 | 26 |
| 19 | 2005 | 26 | |
| 20 | 2005 | 25 |
About Tom Walley
Tom Walley is a scholar working on Economics and Econometrics, General Health Professions, Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 80 papers that have together received 1.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (33 papers), Pharmaceutical Economics and Policy (16 papers), Pharmaceutical industry and healthcare (13 papers), Healthcare Policy and Management (8 papers), Primary Care and Health Outcomes (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (5 papers) and Healthcare cost, quality, practices (5 papers). The work is most often cited by research in Family Practice (90 citations), Geriatrics and Gerontology (161 citations), Medical Terminology (7 citations), Applied Microbiology and Biotechnology (53 citations) and Economics and Econometrics (559 citations). Tom Walley has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Helen Prosser, Simon Maxwell, Alan Haycox, Dyfrig Hughes, Elías Mossialos, Monique F. Mrazek, A Bagust, Rumona Dickson, Y Dündar and Jonathan Cooke. Their work appears in journals such as PharmacoEconomics, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, Social Science & Medicine and International Journal of Technology Assessment in Health Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.